APA (7th ed.) Citation

B, W., D, L., J, F., R, R., Q, S., M, M., . . . O, K. (2018). A dual role of miR-22 modulated by RelA/p65 in resensitizing fulvestrant-resistant breast cancer cells to fulvestrant by targeting FOXP1 and HDAC4 and constitutive acetylation of p53 at Lys382. Oncogenesis, 7(7), 54. https://doi.org/10.1038/s41389-018-0063-5

Chicago Style (17th ed.) Citation

B, Wang, Li D, Filkowski J, Rodriguez-Juarez R, Storozynsky Q, Malach M, Carpenter E, and Kovalchuk O. "A Dual Role of MiR-22 Modulated by RelA/p65 in Resensitizing Fulvestrant-resistant Breast Cancer Cells to Fulvestrant by Targeting FOXP1 and HDAC4 and Constitutive Acetylation of P53 at Lys382." Oncogenesis 7, no. 7 (2018): 54. https://doi.org/10.1038/s41389-018-0063-5.

MLA (9th ed.) Citation

B, Wang, et al. "A Dual Role of MiR-22 Modulated by RelA/p65 in Resensitizing Fulvestrant-resistant Breast Cancer Cells to Fulvestrant by Targeting FOXP1 and HDAC4 and Constitutive Acetylation of P53 at Lys382." Oncogenesis, vol. 7, no. 7, 2018, p. 54, https://doi.org/10.1038/s41389-018-0063-5.